Psychedelic Masterclass Spotlights Ketamine as a Novel Mental Health Medicine

Molecular Masterclass Ketamine Conference 2020

Toronto, Ontario--(Newsfile Corp. - July 30, 2020) - Microdose Psychedelic Insights, along with Bexson Biomedical, The Conscious Fund, and Ketamine Media presents The Ketamine Conference: A Molecular Masterclass, a two-day virtual conference. On August 21st - 22nd, over 30 experts will guide attendees through the potential mental health benefits of ketamine-assisted therapy, along with its intersections with clinical care, research, and business opportunities.

The organizers have invited some of the most ketamine-knowledgeable researchers, clinicians, companies, advocates and experts as they discuss a full spectrum of implications surrounding ketamine-assisted therapies and its relevance to other psychedelic-assisted therapies. The early research into ketamine therapy demonstrates rapid and profound clinical efficacy, challenging current treatment modalities for a variety of mental health conditions such as anxiety, depression, PTSD and substance use disorder. The Molecular Masterclass will feature three main panel types, covering scientific, clinical and industry topics, where attendees will learn about the history of ketamine, its pharmacology, its use in several patient populations, and the risks associated with the drug.

Guest speakers including: Jon Wolfe (Austin Ketamine Clinic), Martha B. Koo, MD (Neuro Wellness Spa), Jeffrey Becker, MD (Bexson Biomedical), Sandhya Prashad, MD (Houston Ketamine Therapeutics), Veronika Gold, MFT (Polaris Insight Center), Rupert McShane, MD (University of Oxford), Gregg Peterson (Bexson Biomedical), and Anthony El Chibani (Ketamine Media).

Ketamine-assisted therapy is undoubtedly opening up unique opportunities for students, physicians, psychotherapists, policy-makers, entrepreneurs, investors, and many more who are engaging with the new wave of psychedelic medicines. This Masterclass is designed to introduce attendees of all types to the latest information and thought leadership on the topic of ketamine for mental health disorders in a way that is comprehensive and interactive.


More details and tickets to the event can be found here.

To request media accreditation, or to arrange interviews with key personnel please contact:

Alex Krause
Alan Aldous Communications


About Microdose Psychedelic Insights

Microdose Psychedelic Insights aims to unlock the potential of psychedelics through Industry events, market intelligence, original, evidence-based content, strategy and community. We enable and empower society at large to make better, more mindful decisions about psychedelics and its intersection with healthcare, medicine and personal growth. We work with the industry's most influential stakeholders, some of the world's best-known brands and an unrivalled network of scientists, researchers, analysts, innovators, investors and advisors.

Jon V. Wolfe, Co-founder and CEO of Austin Ketamine Clinic Jon V. Wolfe, MPA/LP Jon is a veteran Licensed Rescue Paramedic with over twenty years of experience in emergency medicine. After retiring from Austin/Travis County EMS, he found a new role in the emerging field of ketamine infusion therapy. Jon was the event organizer for the American Society of Ketamine Physicians inaugural conference in 2018. His experience within the world of ketamine has consisted of various organizational roles, including ketamine guide, administrative coordinator, director of operations, and independant ketamine consultant. Most recently, Jon and his partner founded Austin Ketamine Clinic to better serve the mental health needs of the community, striving to help make ketamine therapy more accessible and affordable. Located in the heart of central Texas, Austin Ketamine Clinic has become one of the leaders of the industry, promoting outreach/advocacy and clinical research. For more information, visit